• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Perimeter Solutions SA

    9/5/24 1:16:57 PM ET
    $PRM
    Major Chemicals
    Industrials
    Get the next $PRM alert in real time by email
    SC 13G/A 1 PERIMETER_SOLUTIONS_SA.htm FILING PERIMETER SOLUTIONS, SA Schedule 13G


     
    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 13G
     
     
    Under the Securities Exchange Act of 1934
    (Amendment No. 01)*
     
    PERIMETER SOLUTIONS, SA 

    (Name of Issuer)
     
    Ordinary Shares, nominal value $1.00 per share

    (Title of Class of Securities)
     
    L7579L106

    (CUSIP Number)
     
    August 30, 2024

    (Date of Event Which Requires Filing of this Statement)
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
         x  Rule 13d-1(b)
     
         o  Rule 13d-1(c)
     
         o  Rule 13d-1(d)
     
    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
     
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     


     
     

     
     
    CUSIP No.  L7579L106            
     
               
    1   NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
      JPMORGAN CHASE & CO.

    13-2624428
         
    2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)



      (a)   o
      (b)   o
         
    3   SEC USE ONLY
       
       
         
    4   CITIZENSHIP OR PLACE OF ORGANIZATION
       
      Delaware
           
    NUMBER OF SHARES BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH:  5   SOLE VOTING POWER
       
      4,896,997
         
    6   SHARED VOTING POWER
       
      0
         
    7   SOLE DISPOSITIVE POWER
       
      5,200,001
         
    8   SHARED DISPOSITIVE POWER
       
      135
         
    9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
      5,222,376
         
    10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
       
      o
         
    11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
      3.5 %
         
    12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
      HC
     

    FOOTNOTES
       
     
     
     

     
     
    Item 1.


     
    (a)
    Name of Issuer
     
     
    PERIMETER SOLUTIONS, SA


     
    (b)
    Address of Issuer’s Principal Executive Offices
     
     
    12E rue Guillaume Kroll, L-1882 Luxembourg
    Grand Duchy of Luxembourg 352 2668 62-1


    Item 2.


     
    (a)
    Name of Person Filing
     
     
    JPMORGAN CHASE & CO.


     
    (b)
    Address of Principal Business Office or, if none, Residence
     
     
    383 Madison Avenue
    New York, NY 10179


     
    (c)
    Citizenship
     
     
    Delaware


     
    (d)
    Title of Class of Securities
     
     
    Ordinary Shares, nominal value $1.00 per share


     
    (e)
    CUSIP Number
     
     
    L7579L106


     
    Item 3.
    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:


     
    (a)
    o
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).


     
    (b)
    o
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).


     
    (c)
    o
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).


     
    (d)
    o
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).


     
    (e)
    o
    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);


     
    (f)
    o
    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);


     
    (g)
    x
    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);


     
    (h)
    o
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);


     
    (i)
    o
    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);


     
    (j)
    o
    A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J).


     
    (k)
    o
    A group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:


     
     
     

     
     
    Item 4.
    Ownership.
     
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.


     
    (a)
    Amount beneficially owned: 5,222,376


     
    (b)
    Percent of class: 3.5 %


     
    (c)
    Number of shares as to which the person has:


     
    (i)
    Sole power to vote or to direct the vote: 4,896,997


     
    (ii)
    Shared power to vote or to direct the vote: 0


     
    (iii)
    Sole power to dispose or to direct the disposition of: 5,200,001


     
    (iv)
    Shared power to dispose or to direct the disposition of: 135


    Item 5.
    Ownership of Five Percent or Less of a Class
     
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x .
     
     
     
    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.
     
    Not Applicable
     
    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
     
    J.P. Morgan Trust Company of Delaware
    J.P. Morgan Securities LLC
    JPMorgan Chase Bank, National Association
    J.P. Morgan Investment Management Inc.
    J.P. Morgan Private Wealth Advisors LLC
    55I, LLC
     
    Item 8.
    Identification and Classification of Members of the Group
     
    Not Applicable
     
    Item 9.
    Notice of Dissolution of Group
     
    Not Applicable
     
     
     

     
     
     
    Item 10.
    Certification
       
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
     
     


    SIGNATURE


    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
     
      JPMORGAN CHASE & CO.

     
           
    Date: September 05, 2024
    By:
    /s/  Rachel Tsvaygoft  
        Name: Rachel Tsvaygoft  
        Title:  Vice President  
           
     
    Footnotes:


    Attention:
    Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)
     
     



    Get the next $PRM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PRM

    DatePrice TargetRatingAnalyst
    7/9/2026$50.00Overweight
    Analyst
    6/9/2026$48.00Market Outperform
    CJS Securities
    3/31/2026$30.00Neutral → Buy
    UBS
    1/12/2026$31.00Buy → Neutral
    UBS
    3/26/2025$14.00Neutral → Buy
    UBS
    10/11/2023$7.00 → $4.25Buy → Neutral
    UBS
    6/9/2022$14.00Overweight
    Morgan Stanley
    4/14/2022$15.00Buy
    UBS
    More analyst ratings

    $PRM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst initiated coverage on Perimeter Solutions with a new price target

    Analyst initiated coverage of Perimeter Solutions with a rating of Overweight and set a new price target of $50.00

    7/9/26 9:30:24 AM ET
    $PRM
    Major Chemicals
    Industrials

    CJS Securities initiated coverage on Perimeter Solutions with a new price target

    CJS Securities initiated coverage of Perimeter Solutions with a rating of Market Outperform and set a new price target of $48.00

    6/9/26 9:29:28 AM ET
    $PRM
    Major Chemicals
    Industrials

    Perimeter Solutions upgraded by UBS with a new price target

    UBS upgraded Perimeter Solutions from Neutral to Buy and set a new price target of $30.00

    3/31/26 8:06:53 AM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries

    Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman KKR today announced the launch of Allyntra ("Allyntra" or the "Company"), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion. This press release feature

    7/9/26 6:59:00 AM ET
    $KKR
    $PRM
    Investment Managers
    Finance
    Major Chemicals
    Industrials

    Medical Manufacturing Technologies (MMT) Appoints Grant Bowman as President to Lead the Company's Next Chapter of Growth and Innovation

    Medical Manufacturing Technologies (MMT), a Perimeter Solutions company and a leading provider of precision manufacturing technologies for the medical device and advanced industrial markets, today announced the appointment of Grant Bowman as President. Bowman will guide the company's next phase of growth while continuing MMT's customer-first approach and long-standing tradition of solving complex manufacturing challenges. As MMT enters this new phase of leadership, customers can expect the same experienced teams and responsive support across the company's Catheter, Guidewire, Abrasive, and Automation Technologies, and the company’s broader portfolio of solutions. This press release feature

    6/25/26 8:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials

    Perimeter Solutions Reports First Quarter 2026 Financial Results

    First quarter Net Income of $72.9M and Adjusted Net Income of $9.0M Continued value driver execution and recent acquisitions drove first quarter Adjusted EBITDA of $41.2M First quarter Earnings Per Diluted Share of $0.44 and Adjusted Earnings Per Diluted Share of $0.06 Entered into key five-year contracts with the United States Defense Logistics Agency for suppressants and with California Department of Forestry for retardants in April 2026 CLAYTON, Mo., May 06, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE:PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missio

    5/6/26 6:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    SEC Filings

    View All

    SEC Form 144 filed by Perimeter Solutions SA

    144 - Perimeter Solutions, Inc. (0001880319) (Subject)

    6/12/26 5:21:50 PM ET
    $PRM
    Major Chemicals
    Industrials

    SEC Form 144 filed by Perimeter Solutions SA

    144 - Perimeter Solutions, Inc. (0001880319) (Subject)

    6/12/26 5:21:33 PM ET
    $PRM
    Major Chemicals
    Industrials

    Perimeter Solutions SA filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Perimeter Solutions, Inc. (0001880319) (Filer)

    5/28/26 1:37:39 PM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Large owner Windacre Partnership Llc sold $195,609,062 worth of Ordinary shares (5,705,979 units at $34.28) (SEC Form 4)

    4/A - Perimeter Solutions, Inc. (0001880319) (Issuer)

    7/13/26 5:30:32 PM ET
    $PRM
    Major Chemicals
    Industrials

    Large owner Windacre Partnership Llc sold $195,609,062 worth of Ordinary shares (5,705,979 units at $34.28) (SEC Form 4)

    4 - Perimeter Solutions, Inc. (0001880319) (Issuer)

    6/30/26 7:51:15 PM ET
    $PRM
    Major Chemicals
    Industrials

    Chief Executive Officer Khouri Haitham sold $7,284,108 worth of shares (229,535 units at $31.73), decreasing direct ownership by 11% to 1,874,615 units (SEC Form 4)

    4 - Perimeter Solutions, Inc. (0001880319) (Issuer)

    5/22/26 5:39:28 PM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Windacre Partnership Master Fund, Lp bought $3,559,308 worth of Ordinary shares (254,600 units at $13.98) (SEC Form 4)

    4 - Perimeter Solutions, Inc. (0001880319) (Issuer)

    7/1/25 5:30:36 PM ET
    $PRM
    Major Chemicals
    Industrials

    Director Valladares Jorge bought $300,258 worth of Ordinary Shares (42,000 units at $7.15) (SEC Form 4)

    4 - Perimeter Solutions, SA (0001880319) (Issuer)

    6/13/24 5:06:34 PM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    Leadership Updates

    Live Leadership Updates

    View All

    KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries

    Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman KKR today announced the launch of Allyntra ("Allyntra" or the "Company"), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion. This press release feature

    7/9/26 6:59:00 AM ET
    $KKR
    $PRM
    Investment Managers
    Finance
    Major Chemicals
    Industrials

    Medical Manufacturing Technologies (MMT) Appoints Grant Bowman as President to Lead the Company's Next Chapter of Growth and Innovation

    Medical Manufacturing Technologies (MMT), a Perimeter Solutions company and a leading provider of precision manufacturing technologies for the medical device and advanced industrial markets, today announced the appointment of Grant Bowman as President. Bowman will guide the company's next phase of growth while continuing MMT's customer-first approach and long-standing tradition of solving complex manufacturing challenges. As MMT enters this new phase of leadership, customers can expect the same experienced teams and responsive support across the company's Catheter, Guidewire, Abrasive, and Automation Technologies, and the company’s broader portfolio of solutions. This press release feature

    6/25/26 8:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    Financials

    Live finance-specific insights

    View All

    Perimeter Solutions Reports First Quarter 2026 Financial Results

    First quarter Net Income of $72.9M and Adjusted Net Income of $9.0M Continued value driver execution and recent acquisitions drove first quarter Adjusted EBITDA of $41.2M First quarter Earnings Per Diluted Share of $0.44 and Adjusted Earnings Per Diluted Share of $0.06 Entered into key five-year contracts with the United States Defense Logistics Agency for suppressants and with California Department of Forestry for retardants in April 2026 CLAYTON, Mo., May 06, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE:PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missio

    5/6/26 6:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials

    Perimeter Announces Date for First Quarter 2026 Earnings Call

    CLAYTON, Mo., April 21, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions (NYSE: PRM) ("Perimeter" or the "Company"), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, announced today it will release its financial results for the first quarter 2026 on Wednesday, May 6, 2026, before the market opens. The Company will host a conference call to discuss these results at 8:30 a.m. ET on the same day. The presentation will be led by CEO Haitham Khouri, CFO Kyle Sable, and Head of Investor Relations Seth Barker. The live webcast of the call can be accessed through Perimeter's investor relations website at 

    4/21/26 4:05:00 PM ET
    $PRM
    Major Chemicals
    Industrials

    Perimeter Solutions Reports Fourth Quarter 2025 Financial Results

    Full year Net Loss of $206.4M and Adjusted Net Income of $206.7M Continued value driver execution drove full year Adjusted EBITDA of $331.7M Full year Loss Per Diluted Share of $1.37 and Adjusted Earnings Per Diluted Share of $1.34 Specialty Products Segment acquired add-on product lines in Q4 2025, and MMT in Q1 2026 CLAYTON, Mo., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE:PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, today reported financial results for its fourth quarter, and full year, ended December 3

    2/26/26 6:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials

    $PRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Perimeter Solutions SA

    SC 13G/A - Perimeter Solutions, Inc. (0001880319) (Subject)

    11/22/24 6:42:15 PM ET
    $PRM
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Perimeter Solutions SA

    SC 13G/A - Perimeter Solutions, SA (0001880319) (Subject)

    9/5/24 1:16:57 PM ET
    $PRM
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Perimeter Solutions SA (Amendment)

    SC 13G/A - Perimeter Solutions, SA (0001880319) (Subject)

    2/14/24 4:00:13 PM ET
    $PRM
    Major Chemicals
    Industrials